LINK Medical   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Oslo Norway (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (2)

Key: LINK Medical (0) Acquired (2)

adalimumab (humira) (1 trial)

naltrexone (revia) (1 trial)

Drugs in Phase 3 Trials (2)

Key: LINK Medical (0) Acquired (2)

cromoglicic acid (Intal) (3 trials)

ibuprofen (motrin) (2 trials)

Drugs in Phase 2 Trials (4)

Key: LINK Medical (0) Acquired (4)

calmangafodipir (1 trial)

haemophilus influenzae type b conjugate vaccine (HibTITER) (1 trial)

oxytocin (syntocinon) (1 trial)

salicylic acid (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 7
  • # of Trial APIs: 8